Diploma (LON:DPLM) Shares Up 0.4% – Should You Buy?

Diploma PLC (LON:DPLM) was up 0.4% on Wednesday . The company traded as high as GBX 4,878 ($65.33) and last traded at GBX 4,878 ($65.33). Approximately 11,769,962 shares traded hands during mid-day trading, an increase of 1,964% from the average daily volume of 570,198 shares. The stock had previously closed at GBX 4,860 ($65.09).

Diploma Price Performance

The firm has a fifty day moving average of GBX 3,949.28 and a two-hundred day moving average of GBX 4,253.28. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The company has a market capitalization of £6.50 billion, a PE ratio of 56.05, a PEG ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLM) last issued its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share (EPS) for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. Research analysts anticipate that Diploma PLC will post 163.7995512 EPS for the current fiscal year.

Insider Buying and Selling at Diploma

In other Diploma news, insider David S. Lowden bought 750 shares of Diploma stock in a transaction dated Friday, March 21st. The shares were purchased at an average cost of GBX 3,928 ($52.60) per share, with a total value of £29,460 ($39,453.60). Also, insider Ian El-Mokadem purchased 500 shares of the company’s stock in a transaction that occurred on Monday, March 24th. The stock was acquired at an average cost of GBX 3,948 ($52.87) per share, with a total value of £19,740 ($26,436.32). 0.52% of the stock is currently owned by corporate insiders.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.